Boston Scientific Corp. Stock Falls 4.1%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Boston Scientific Corp. slipped 4.1% to $43.10 on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.6% to 7,591.70 and Dow Jones Industrial Average falling 0.6% to 52,064.10.

This was the stock's third consecutive day of losses.

Boston Scientific Corp. closed 60.1% below its 52-week high of $108.07, which the company reached on September 10th.

The stock underperformed when compared to some of its peers, as Abbott Laboratories fell 1.8% to $103.36, Medtronic PLC fell 0.3% to $91.62, and Stryker Corp. fell 1.95% to $270.01.

Trading volume totaled 22.6 million, compared to the 50-day average of 19.9 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 10, 2026 16:35 ET (20:35 GMT)